Epidemiology

You have full text access to this OnlineOpen article

A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer

  1. Margaret A. Gates1,2,†,*,
  2. Shelley S. Tworoger1,2,
  3. Jonathan L. Hecht3,
  4. Immaculata De Vivo1,2,
  5. Bernard Rosner1,4,
  6. Susan E. Hankinson1,2

Article first published online: 30 APR 2007

DOI: 10.1002/ijc.22790

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 10, pages 2225–2232, 15 November 2007

Additional Information

How to Cite

Gates, M. A., Tworoger, S. S., Hecht, J. L., De Vivo, I., Rosner, B. and Hankinson, S. E. (2007), A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int. J. Cancer, 121: 2225–2232. doi: 10.1002/ijc.22790

Author Information

  1. 1

    Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  2. 2

    Department of Epidemiology, Harvard School of Public Health, Boston, MA

  3. 3

    Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

  4. 4

    Department of Biostatistics, Harvard School of Public Health, Boston, MA

  1. †

    Fax: +617-525-2008.

*Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115, USA

Publication History

  1. Issue published online: 25 SEP 2007
  2. Article first published online: 30 APR 2007
  3. Manuscript Accepted: 21 MAR 2007
  4. Manuscript Received: 22 FEB 2007

Funded by

  • National Cancer Institute, National Institutes of Health. Grant Numbers: CA87969, P50 CA105009, T32 CA009001, R25 CA098566

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (109K)

References

  • 1
    Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Arslan A, Beeson WL, Buring JE, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Jacobs DRJr, et al. Dairy products and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 364–72.
  • 2
    Le Marchand L. Cancer preventive effects of flavonoids—a review. Biomed Pharmacother 2002; 56: 296–301.
  • 3
    López-Lázaro M. Flavonoids as anticancer agents: structure-activity relationship study. Curr Med Chem Anticancer Agents 2002; 2: 691–714.
  • 4
    Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002; 22: 19–34.
  • 5
    Ren W, Qiao Z, Wang H, Zhu L, Zhang L. Flavonoids: promising anticancer agents. Med Res Rev 2003; 23: 519–34.
    Direct Link:
  • 6
    Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 2003; 133: 3248S–3254S.
  • 7
    Aherne SA, O'Brien NM. Dietary flavonols: chemistry, food content, and metabolism. Nutrition 2002; 18: 75–81.
  • 8
    McCann SE, Freudenheim JL, Marshall JR, Graham S. Risk of human ovarian cancer is related to dietary intake of selected nutrients, phytochemicals and food groups. J Nutr 2003; 133: 1937–42.
  • 9
    Zhang M, Xie X, Lee AH, Binns CW. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast China. Nutr Cancer 2004; 49: 125–30.
  • 10
    Chang ET, Lee VS, Canchola AJ, Clarke CA, Purdie DM, Reynolds P, Anton-Culver H, Bernstein L, Deapen D, Peel D, Pinder R, Ross RK, et al. Diet and risk of ovarian cancer in the California Teachers Study cohort. Am J Epidemiol 2007; 165: 802–13.
  • 11
    Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51–65.
  • 12
    Willett WC, Sampson L, Browne ML, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 1988; 127: 188–99.
  • 13
    Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858–67.
  • 14
    Hertog MG, Hollman PC, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 1992; 40: 2379–83.
  • 15
    Sampson L, Rimm E, Hollman PC, de Vries JH, Katan MB. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc 2002; 102: 1414–20.
  • 16
    Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 1994; 140: 1016–9.
  • 17
    Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol 1984; 119: 837–9.
  • 18
    Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol 1986; 124: 17–27.
  • 19
    Kurian AW, Balise RR, McGuire V, Whittemore AS. Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 2005; 96: 520–30.
  • 20
    Fang J, Xia C, Cao Z, Zheng JZ, Reed E, Jiang BH. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J 2005; 19: 342–53.
  • 21
    Fang J, Zhou Q, Liu LZ, Xia C, Hu X, Shi X, Jiang BH. Apigenin inhibits tumor angiogenesis through decreasing HIF-1α and VEGF expression. Carcinogenesis 2007; 28: 858–64.
  • 22
    Kiani F, Knutsen S, Singh P, Ursin G, Fraser G. Dietary risk factors for ovarian cancer: the Adventist Health Study (United States). Cancer Causes Control 2006; 17: 137–46.
  • 23
    Schulz M, Lahmann PH, Boeing H, Hoffmann K, Allen N, Key TJ, Bingham S, Wirfalt E, Berglund G, Lundin E, Hallmans G, Lukanova A, et al. Fruit and vegetable consumption and risk of epithelial ovarian cancer: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2005; 14: 2531–5.
  • 24
    Koushik A, Hunter DJ, Spiegelman D, Anderson KE, Arslan AA, Beeson WL, van den Brandt PA, Buring JE, Cerhan JR, Colditz GA, Fraser GE, Freudenheim JL, et al. Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 2160–7.
  • 25
    Mommers M, Schouten LJ, Goldbohm RA, van den Brandt PA. Consumption of vegetables and fruits and risk of ovarian carcinoma. Cancer 2005; 104: 1512–9.
    Direct Link:
  • 26
    Pan SY, Ugnat AM, Mao Y, Wen SW, Johnson KC, The Canadian Cancer Registries Epidemiology Research Group. A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1521–7.
  • 27
    Schulz M, Lahmann PH, Riboli E, Boeing H. Dietary determinants of epithelial ovarian cancer: a review of the epidemiologic literature. Nutr Cancer 2004; 50: 120–40.
  • 28
    Galeone C, Pelucchi C, Levi F, Negri E, Franceschi S, Talamini R, Giacosa A, La Vecchia C. Onion and garlic use and human cancer. Am J Clin Nutr 2006; 84: 1027–32.
  • 29
    Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Hampton JM, Willett WC, Egan KM. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 2006; 119: 2423–7.
    Direct Link:
  • 30
    Gallus S, Talamini R, Bosetti C, Negri E, Montella M, Franceschi S, Giacosa A, La Vecchia C. Pizza consumption and the risk of breast, ovarian and prostate cancer. Eur J Cancer Prev 2006; 15: 74–6.
  • 31
    Larsson SC, Wolk A. Tea consumption and ovarian cancer risk in a population-based cohort. Arch Intern Med 2005; 165: 2683–6.
  • 32
    Jordan SJ, Purdie DM, Green AC, Webb PM. Coffee, tea and caffeine and risk of epithelial ovarian cancer. Cancer Causes Control 2004; 15: 359–65.
  • 33
    Zhang M, Binns CW, Lee AH. Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev 2002; 11: 713–8.
  • 34
    Kuper H, Titus-Ernstoff L, Harlow BL, Cramer DW. Population based study of coffee, alcohol and tobacco use and risk of ovarian cancer. Int J Cancer 2000; 88: 313–8.
    Direct Link:
  • 35
    Zheng W, Doyle TJ, Kushi LH, Sellers TA, Hong CP, Folsom AR. Tea consumption and cancer incidence in a prospective cohort study of postmenopausal women. Am J Epidemiol 1996; 144: 175–82.
  • 36
    La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. Tea consumption and cancer risk. Nutr Cancer 1992; 17: 27–31.
  • 37
    Miller DR, Rosenberg L, Kaufman DW, Helmrich SP, Schottenfeld D, Lewis J, Stolley PD, Rosenshein N, Shapiro S. Epithelial ovarian cancer and coffee drinking. Int J Epidemiol 1987; 16: 13–7.
  • 38
    Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Buring JE, Freudenheim JL, Goldbohm RA, Harnack L, Hankinson SE, Larsson SC, Leitzmann M, McCullough ML, et al. Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 2006; 94: 757–62.
  • 39
    Webb PM, Purdie DM, Bain CJ, Green AC. Alcohol, wine, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 592–9.
  • 40
    Schouten LJ, Zeegers MP, Goldbohm RA, van den Brandt PA. Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 2004; 15: 201–9.
  • 41
    Modugno F, Ness RB, Allen GO. Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer. Obstet Gynecol 2003; 102: 1336–43.
  • 42
    Goodman MT, Tung KH. Alcohol consumption and the risk of borderline and invasive ovarian cancer. Obstet Gynecol 2003; 101: 1221–8.
  • 43
    Tavani A, Gallus S, Dal Maso L, Franceschi S, Montella M, Conti E, La Vecchia C. Coffee and alcohol intake and risk of ovarian cancer: an Italian case-control study. Nutr Cancer 2001; 39: 29–34.
  • 44
    La Vecchia C, Negri E, Franceschi S, Parazzini F, Gentile A, Fasoli M. Alcohol and epithelial ovarian cancer. J Clin Epidemiol 1992; 45: 1025–30.
  • 45
    Baker JA, Boakye K, McCann SE, Beehler GP, Rodabaugh KJ, Villella JA, Moysich KB. Consumption of black tea or coffee and risk of ovarian cancer. Int J Gynecol Cancer 2007; 17: 50–4.
    Direct Link:
  • 46
    Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004; 266: 37–56.
  • 47
    Marx J. Cancer research. Inflammation and cancer: the link grows stronger. Science 2004; 306: 966–8.
  • 48
    Ness RB, Cottreau C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91: 1459–67.
  • 49
    Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A. 1. Life Sci 2001; 68: 921–31.
  • 50
    Harris GK, Qian Y, Leonard SS, Sbarra DC, Shi X. Luteolin and chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J Nutr 2006; 136: 1517–21.
  • 51
    Hu C, Kitts DD. Luteolin and luteolin-7-O-glucoside from dandelion flower suppress iNOS and COX-2 in RAW264.7 cells. Mol Cell Biochem 2004; 265: 107–13.
  • 52
    Moon YJ, Wang X, Morris ME. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 2006; 20: 187–210.
  • 53
    Birt DF, Hendrich S, Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001; 90: 157–77.
  • 54
    Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 2005; 14: 98–107.
  • 55
    Gercel-Taylor C, Feitelson AK, Taylor DD. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Res 2004; 24: 795–800.
  • 56
    Huh SW, Bae SM, Kim YW, Lee JM, Namkoong SE, Lee IP, Kim SH, Kim CK, Ahn WS. Anticancer effects of (−)-epigallocatechin- 3-gallate on ovarian carcinoma cell lines. Gynecol Oncol 2004; 94: 760–8.
  • 57
    Scambia G, Ranelletti FO, Panici PB, Piantelli M, Bonanno G, De Vincenzo R, Ferrandina G, Rumi C, Larocca LM, Mancuso S. Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br J Cancer 1990; 62: 942–6.
  • 58
    Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, Lovegrove JA. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr 2006; 96: 482–8.
  • 59
    Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 2005; 81: 230S–242S.
View Full Article (HTML) Get PDF (109K)